Results 171 to 180 of about 67,545 (209)
Some of the next articles are maybe not open access.
C-Type Lectin Receptors in Antifungal Immunity
2020Most fungal species are harmless to humans and some exist as commensals on mucocutaneous surfaces. Yet many fungi are opportunistic pathogens, causing life-threatening invasive infections when the immune system becomes compromised. The fungal cell wall contains conserved pathogen-associated molecular patterns (PAMPs), which allow the immune system to ...
Christina, Nikolakopoulou +2 more
openaire +2 more sources
C-Type Lectin Receptors Orchestrate Antifungal Immunity
Future Microbiology, 2013Fungal infections are an emerging threat for human health. A coordinated host immune response is fundamental for successful elimination of an invading fungal microbe. A panel of C-type lectin receptors expressed on antigen-presenting dendritic cells enable innate recognition of fungal cell wall carbohydrates and tailors adaptive responses via the ...
Brigitte A, Wevers +2 more
openaire +2 more sources
Insect C-type lectins in innate immunity
Developmental & Comparative Immunology, 2018C-type lectins (CTLs) are a family of proteins that contain characteristic modules of carbohydrate-recognition domains (CRDs) and they possess the binding activity to ligands in a calcium-dependent manner. CTLs play important roles in animal immune responses, and in insects, they are involved in opsonization, nodule formation, agglutination ...
Xiaofeng Xia +3 more
openaire +2 more sources
Myeloid C-type lectins in innate immunity
Nature Immunology, 2006C-type lectins expressed on myeloid cells comprise a family of proteins that share a common structural motif, and some act as receptors in pathogen recognition. But just as the presence of leucine-rich repeats alone is not sufficient to define a Toll-like receptor, the characterization of C-type lectin receptors in innate immunity requires the ...
Robinson, Matthew J +4 more
openaire +2 more sources
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Nature Reviews Drug Discovery, 2023P V Kolkhir +2 more
exaly
Targeting inflammation in the treatment of type 2 diabetes: time to start
Nature Reviews Drug Discovery, 2014Marc Y Donath
exaly
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Nature Reviews Drug Discovery, 2011Frank D Waldron-Lynch
exaly

